Skip to main content
. 2020 Sep 1;10:14365. doi: 10.1038/s41598-020-71427-7

Table 2.

Association of the HNF1B/EZH2/ECI2 H-score with the type of lesion, based on 119 patients with prostate lesion. Significant p-values are indicated in bold.

Type of lesion N HNF1B
mean ± SD
HNF1B
median
p-value EZH2
mean ± SD
EZH2 median p-value ECI2
mean ± SD
ECI2
median
p-value
0.925  < 0.001  < 0.001
PC 101 19.5 ± 36.6 0 41.8 ± 39.6 30 156.6 ± 58.8 160
AH 18 11.7 ± 16.9 0 5.9 ± 7.7 4.5 96.1 ± 21.7 100

PC prostate cancer, AH adenomyomatous hyperplasia.